Global Economics names Contact Financial Holding the Fastest Growing Finance Company in Egypt    EGYPS 2022 begins a year of strategic energy dialogue    Egypt's stocks mixed on Tuesday as main gauge EGX 30 falls 0.63%    Egypt works on charting cooperation strategies with international institutions for 5 years: Al-Mashat    Maha karara joins AAIB as Head of Corporate Communications, Sustainability    Over 2.4 million newborns examined for hearing impairment: Health Ministry    Netflix releases trailer of Arab adaption of 'Perfect Strangers' film    Balqees to headline concert celebrating launch of streaming giant LIVENow in MENA    Sawsan Badr to be honoured at Aswan Women Film Festival    Al-Sisi follows up on 'Great Transfiguration Project' in St. Catherine    Cairo, London stress need to strengthen cooperation to face climate change    Foreigners account for 22.6% of Egypt's T-bills issuances in 1H 2021: CBE    MP Abdel Hady Al-Qasby calls government to facilitate and support NGOs    Egypt's ambassador to Italy passes away    Egypt confirms readiness to help African countries face terrorism and extremism    An estimated 235 million people needed humanitarian assistance and protection in 2021, an increase of 40% compared to 2020: IOM Egypt    Egypt, DRC discuss water cooperation during WYF    Egypt, DR Congo discuss boosting bilateral cooperation during WYF    Cameroonian police probe assault on three Algerian journalists covering AFCON    Pharaohs start AFCON 2021 campaign with fierce clash against Nigeria    Foreign Ministry opens capacity building course for French-speaking African diplomats    BRICS development bank admits Egypt as new member    Nermien Ismail Schools opens a new campus in O'West    Netherlands Embassy, E7kky Magazine celebrate success of 21 Egyptian women    Women make up 45% of Egyptian Atomic Energy Authority staff    Yas Island hosts travel partners at Formula 1 Etihad Airways Abu Dhabi Grand Prix 2021    Olaf Scholz becomes Germany's new leader, ending Merkel 16-year historic era    Egypt's trade with Nile basin countries climbs 26% y-o-y in 9 months    The unvaccinated prohibited from entry to Egypt state institutions starting December 1    Egypt's iron and steel exports jump 197% in 8 months    Ethiopia halts work at its embassy in Egypt for 'economic reasons'    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Russia says it's in sync with US, China, Pakistan on Taliban    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    Brazil calls up 8 EPL players for World Cup qualifying    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Sisi calls on House, Senate to commence second legislative sessions on 3, 5 October    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    Qa'a play showing at Lycee El Horreya Theatre, Alexandria is a must go    On International Museum Day, Egypt opens two new museums at Cairo Airport    Old Cairo's Al-Fustat will be revamped on Egyptian President's directives    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

FDA authorises IQOS marketing as modified risk tobacco product
Decision ensures users can make informed switch to IQOS as better choice to smoking
Published in Daily News Egypt on 13 - 07 - 2020

The US Food and Drug Administration (FDA) authorised, on Sunday, the marketing of the IQOS, Philip Morris International's (PMI) electrically heated tobacco device, as a modified risk tobacco product (MRTP).
In doing so, the agency noted that an IQOS exposure modification order is appropriate in promoting public health.
The decision demonstrates that IQOS is a different product to standard tobacco, and a better choice for adults who would otherwise continue smoking. The device is the first and only electronic nicotine product to be granted marketing orders through the FDA's MRTP process
The FDA authorised marketing of IQOS devices as a unit that heats tobacco but does not burn it. With this heating system in place, the production of harmful and potentially harmful chemicals are significantly reduced.
Scientific studies have shown that switching completely from conventional cigarettes to an IQOS device reduces the human body's exposure to harmful or potentially harmful chemicals.
The agency concluded that the available scientific evidence demonstrates that IQOS devices are expected to provide reduced health impairments in comparison to standard cigarettes. This takes into account both users of tobacco products and those who do not currently use them.
The FDA's decision further builds on the emerging independent international scientific consensus that IQOS devices are a better choice than continuing to smoke standard cigarettes. It also follows the agency's April 2019 decision authorising for IQOS devices to be sold in the US.
Additionally, the FDA's decision is an important example of how governments and public health organisations can regulate smoke-free alternatives to differentiate them from cigarettes to ensure greater health protections.
The decision follows a review of the extensive scientific evidence package PMI submitted to the FDA in December 2016 to support its MRTP applications.
"The decision makes it possible to inform adults that switching completely to IQOS is a better choice than continuing to smoke," PMI CEO André Calantzopoulos said, "The FDA determined that scientific studies show that switching completely from conventional cigarettes to IQOS reduces exposure to harmful or potentially harmful chemicals."
Calantzopoulos added that IQOS is a different product to combustible cigarettes and must be regulated differently, as the FDA has recognised. The decision reflects the urgent need for a different, cooperative approach to achieve a smoke-free future.
"We are excited that this important decision will help guide the choices of adult smokers in the US, and that the best health choice is to never start smoking or to quit altogether," Calantzopoulos said, "For those who don't quit, the best thing they can do is switch to a scientifically substantiated smoke-free product."
He added that PMI estimates that, as of 31 March, statistics show approximately 10.6 million adult smokers worldwide have already stopped smoking and switched to IQOS.
"We believe that this decision can help to further accelerate the transition of US adults away from cigarettes" Calantzopoulos said, "We, along with our licensee Altria, are committed to guarding against unintended use and fully support FDA's focus on protecting youth."
"Moreover, the decision is a result of our ongoing commitment to put science at the forefront as we continue on our quest to replace cigarettes with smoke-free alternatives as quickly as possible," he added.
Vassilis Gkatzelis, Managing Director of Philip Morris Egypt & Levant said, "This is a historic milestone. The FDA reviewed all available science and confirmed that IQOS is distinctly different from cigarettes, because it has been demonstrated to reduce exposure to harmful chemicals. Now is the time to rapidly shift adult smokers away from cigarettes. Scientifically substantiated better alternatives like IQOS represent a public health opportunity."
Philip Morris International (PMI) is leading a transformation in the tobacco industry, to ultimately replace cigarettes with smoke-free products and create a smoke-free future. It looks to create products that benefit adults who would otherwise continue to smoke.

Clic here to read the story from its source.